You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKinsey
Harvard Business School
AstraZeneca
Baxter

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Patent: 10,017,492

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,017,492
Title:Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
Abstract: Provided are an isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof. The isoindoline derivative and the pharmaceutical composition thereof can regulate the production or activity of immunological cytokines, thus effectively treating cancer and inflammatory disease. ##STR00001##
Inventor(s): Ge; Chuansheng (Shanghai, CN), Lee; Wen-Cherng (Shanghai, CN), Liao; Baisong (Shanghai, CN), Zhang; Lei (Shanghai, CN)
Assignee: KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)
Application Number:15/523,651
Patent Claims:see list of patent claims

Details for Patent 10,017,492

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX Orphan search
Merck Sharp Dohme KEYTRUDA pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 001 2014-09-04   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04   Start Trial KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) 2034-10-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Express Scripts
Boehringer Ingelheim
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.